Risk stratification for SARS-CoV-2-related venous thromboembolic events: time for a new paradigm?

Stuart D Marshall Laura V Duggan

Published in: Anaesthesia (2021)

Keyphrases

sars cov
respiratory syndrome coronavirus
atrial fibrillation
drug induced